Ameriprise’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $90.1M | Buy |
170,034
+67,616
| +66% | +$31.2M | 0.02% | 650 |
|
|
2026
Q1 | $49.2M | Sell |
102,418
-22,537
| -18% | -$11.5M | 0.01% | 881 |
|
|
2025
Q4 | $70.2M | Buy |
124,955
+7,099
| +6% | +$4.03M | 0.02% | 704 |
|
|
2025
Q3 | $60.7M | Buy |
117,856
+19,699
| +20% | +$8.6M | 0.01% | 781 |
|
|
2025
Q2 | $30.8M | Sell |
98,157
-139,233
| -59% | -$41.8M | 0.01% | 1113 |
|
|
2025
Q1 | $72.3M | Buy |
237,390
+6,226
| +3% | +$2.09M | 0.02% | 678 |
|
|
2024
Q4 | $76.8M | Buy |
231,164
+40,727
| +21% | +$13.8M | 0.02% | 654 |
|
|
2024
Q3 | $63.6M | Buy |
190,437
+33,990
| +22% | +$12.9M | 0.02% | 737 |
|
|
2024
Q2 | $64.4M | Buy |
156,447
+31,981
| +26% | +$12.7M | 0.02% | 692 |
|
|
2024
Q1 | $50.3M | Sell |
124,466
-99,437
| -44% | -$35M | 0.01% | 797 |
|
|
2023
Q4 | $68.6M | Buy |
223,903
+21,055
| +10% | +$5.68M | 0.02% | 647 |
|
|
2023
Q3 | $49.1M | Sell |
202,848
-11,196
| -5% | -$2.86M | 0.02% | 745 |
|
|
2023
Q2 | $51.4M | Buy |
214,044
+43,327
| +25% | +$9M | 0.02% | 746 |
|
|
2023
Q1 | $32.1M | Buy |
170,717
+2,939
| +2% | +$608K | 0.01% | 972 |
|
|
2022
Q4 | $35.6M | Sell |
167,778
-29,270
| -15% | -$5.85M | 0.01% | 877 |
|
|
2022
Q3 | $30.9M | Sell |
197,048
-11,758
| -6% | -$1.88M | 0.01% | 913 |
|
|
2022
Q2 | $31.3M | Sell |
208,806
-11,833
| -5% | -$1.71M | 0.01% | 935 |
|
|
2022
Q1 | $36.1M | Sell |
220,639
-111,987
| -34% | -$18.5M | 0.01% | 956 |
|
|
2021
Q4 | $72.3M | Buy |
332,626
+21,249
| +7% | +$4.45M | 0.02% | 680 |
|
|
2021
Q3 | $58.9M | Buy |
311,377
+86
| +0% | +$15.7K | 0.02% | 691 |
|
|
2021
Q2 | $55M | Buy |
311,291
+15,331
| +5% | +$2.65M | 0.02% | 754 |
|
|
2021
Q1 | $48.5M | Buy |
295,960
+3,491
| +1% | +$534K | 0.02% | 779 |
|
|
2020
Q4 | $40.7M | Buy |
292,469
+15,439
| +6% | +$1.95M | 0.01% | 840 |
|
|
2020
Q3 | $30.9M | Sell |
277,030
-124,051
| -31% | -$14.3M | 0.01% | 850 |
|
|
2020
Q2 | $37.3M | Sell |
401,081
-60,112
| -13% | -$5.12M | 0.02% | 732 |
|
|
2020
Q1 | $33.8M | Sell |
461,193
-19,763
| -4% | -$1.72M | 0.02% | 685 |
|
|
2019
Q4 | $40.4M | Buy |
480,956
+222,251
| +86% | +$17.2M | 0.02% | 793 |
|
|
2019
Q3 | $21.7M | Sell |
258,705
-62,211
| -19% | -$4.7M | 0.01% | 1081 |
|
|
2019
Q2 | $21M | Sell |
320,916
-261,294
| -45% | -$15.1M | 0.01% | 1126 |
|
|
2019
Q1 | $34.3M | Sell |
582,210
-130,218
| -18% | -$7.78M | 0.02% | 834 |
|
|
2018
Q4 | $37.7M | Sell |
712,428
-8,340
| -1% | -$458K | 0.02% | 728 |
|
|
2018
Q3 | $44.1M | Buy |
720,768
+44,281
| +7% | +$2.42M | 0.02% | 813 |
|
|
2018
Q2 | $29.1M | Buy |
676,487
+50,525
| +8% | +$2.04M | 0.01% | 938 |
|
|
2018
Q1 | $21.8M | Buy |
625,962
+283,099
| +83% | +$10.3M | 0.01% | 1069 |
|
|
2017
Q4 | $12.4M | Sell |
342,863
-73,238
| -18% | -$2.57M | 0.01% | 1442 |
|
|
2017
Q3 | $13.3M | Buy |
416,101
+195,284
| +88% | +$5.97M | 0.01% | 1356 |
|
|
2017
Q2 | $6.4M | Buy |
+220,817
| New | +$6.19M | ﹤0.01% | 1891 |
|
Other funds holding MEDP
WA
Ameriprise's MEDP Position: Q2 2026 in Review
Ameriprise increased its Medpace (MEDP) stake by 66% in Q2 2026, buying an estimated $31.2M and bringing the position to 170,034 shares worth $90.1M. The position accounts for 0.02% of the portfolio, ranked #650.
Ameriprise first reported a position in MEDP in Q2 2017 and has held it in 37 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Ameriprise held 170,034 shares of Medpace worth $90.1M as of Q2 2026.
- Ameriprise bought 67,616 Medpace shares in Q2 2026, an estimated $31.2M.
- Medpace made up 0.02% of Ameriprise's portfolio in Q2 2026, its #650 holding.
- Ameriprise first reported a position in Medpace in Q2 2017 and has held it in 37 quarters since.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.